Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials.
Halimi, J-M
Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials. [electronic resource] - Diabetes & metabolism Dec 2009 - 425-30 p. digital
Publication Type: Journal Article; Review
1878-1780
10.1016/j.diabet.2009.05.003 doi
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Antihypertensive Agents--therapeutic use
Blood Pressure--drug effects
Diabetic Nephropathies--drug therapy
Humans
Kidney--drug effects
Proteinuria--prevention & control
Randomized Controlled Trials as Topic
Renin-Angiotensin System--drug effects
Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials. [electronic resource] - Diabetes & metabolism Dec 2009 - 425-30 p. digital
Publication Type: Journal Article; Review
1878-1780
10.1016/j.diabet.2009.05.003 doi
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Antihypertensive Agents--therapeutic use
Blood Pressure--drug effects
Diabetic Nephropathies--drug therapy
Humans
Kidney--drug effects
Proteinuria--prevention & control
Randomized Controlled Trials as Topic
Renin-Angiotensin System--drug effects